Spectrum Vascular is a leading innovator in vascular access solutions, committed to delivering excellence and advancing patient care. As a key member of our team, the Customer Service Representative will be primarily responsible for supporting our hospital and clinical customers, including our Direct and Distributor partners, ensuring accurate and timely order processing, and helping resolve inquiries with care and professionalism. Additional responsibilities include monitoring the company’s Electronic Data Information (EDI) automatic order fulfillment system; including receiving, verifying and processing electronically submitted data. Reporting directly to the Manager of Customer Service, this role is crucial in ensuring our customers receive concierge-level service and fostering positive relationships that reflect Spectrum Vascular’s commitment to quality and service.

Role Responsibilities:

· Manage complex customer situations, responding promptly and effectively to address inquiries and resolve issues.

· Receive and process orders for vascular access products and services via email, phone, and electronic systems.

· Responsible for day-to-day monitoring, corrections and releasing of all purchase orders submitted via EDI and GFAX (fax orders converted to electronic transmission) in a timely manner to meet customer expectations.

· Enter and update orders and account information with accuracy and urgency.

· Maintain proper documentation on all orders containing processing exceptions and requiring approval.

· Maintain proper documentation of customer phone interactions.

· Collaborate closely with internal teams (sales, logistics, finance, regulatory affairs, quality assurance and marketing) to ensure seamless service and support.

· Inform field representatives of customer issues and inquiries.

· Provide timely responses to all inquiries from internal and external stakeholders.

· Process product returns.

· Service our EDI customers by facilitating relevant customer information as requested and needed.

· Support hospitals and sales representatives with account setups and updates.

· Apply comprehensive understanding of products, services, and organizational policies to daily work.

Role Competencies:

· Excellent interpersonal and communication skills, both oral and written

· Sharp attention to detail and ability to multitask

· Exceptional organizational skills

· Customer-focused and collaborative team player

· Self-motivated and adaptable to changing priorities

· Performs effectively under pressure

· Proactive in identifying opportunities to improve service and processes

· Ability to work independently and thrive in a fast-paced environment

Role Requirements

· At least 2 years of experience in customer service, sales support and order processing (medical device industry experience preferred)

· EDI experience within the GHX platform is a plus

· Proficient in Microsoft Office

· ERP system experience

Spectrum Vascular is an Equal Opportunity Employer and committed to creating a diverse and inclusive company culture. Spectrum Vascular does not discriminate against candidates and employees because of their disability, sex, race, gender identity, sexual orientation, religion,
national origin, age, veteran status, or any other protected status under the law.

About the company

Spectrum Vascular makes vascular access and medication management devices. Its products include central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midlines, arterial lines, and intraosseous needles designed to reduce infections and thrombus formation, with antimicrobial protection features like SV Spectrum and SV BioFlo. The company built its portfolio by acquiring Cook Medical’s vascular access lines in 2023 and AngioDynamics’ PICCs, midlines, and tip-location products in 2024, creating a broad platform for care across settings. Backed by private investors, Spectrum Vascular plans to grow through strategic leadership and expansion, aiming to lower infection risk and complications for patients and caregivers.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

White Plains, New York

Founded

N/A

Get referred to Spectrum Vascular

See people who can refer or advise you

Simplify's Take

What believers are saying

SK Capital’s March 2025 recapitalization funds expansion and accelerates commercial hiring.
FDA cleared Spectrum’s Arterial Pressure Monitoring Set/Tray on June 26, 2026.
Piccolo’s May 2026 Nav+ Stylet placements create an installed-base story for 2027 sales.

What critics are saying

The June 2026 Piccolo acquisition risks integration failure across commercial, regulatory, and manufacturing teams.
Hospitals can reject ECGuide adoption if clinicians keep defaulting to chest X-rays in 2027.
Becton Dickinson, Teleflex, and ICU Medical can compress margins with broader purchasing contracts.

What makes Spectrum Vascular unique

Spectrum Vascular bundled Cook, AngioDynamics, and Piccolo portfolios into one vascular-access platform.
Piccolo’s 510(k)-cleared blood-flow sensing guidance eliminates confirmatory chest X-rays.
SV Spectrum and SV BioFlo combine antimicrobial and thrombus-reduction features across catheter lines.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options
Health Insurance
Dental Insurance
Vision Insurance
Flexible Work Hours
Paid Vacation
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Stock Options
Company Equity
Wellness Program

Growth & Insights and Company News

6 month growth

-5%

1 year growth

21%

2 year growth

21%

GlobeNewswire

Oct 22nd, 2026

Vitaquest International appoints Martin Gargiule as Chief Financial Officer.

Vitaquest International appoints Martin Gargiule as Chief Financial Officer. Finance executive with more than 25 years across consumer health, pharmaceutical, and manufacturing businesses joins Vitaquest's growing leadership team. WEST CALDWELL, N.J., Oct. 22, 2026 (GLOBE NEWSWIRE) - Leading contract manufacturer Vitaquest International LLC today announced the appointment of Martin Gargiule as Chief Financial Officer, effective October 12, 2026. Gargiule brings more than 25 years of finance leadership across consumer health, pharmaceutical, and manufacturing companies, with deep experience building scalable finance organizations, implementing enterprise systems, and integrating growing businesses. Gargiule's appointment is the latest step in a deliberate build-out of Vitaquest's leadership team since Tim Condron was named Chief Executive Officer in April. Together with the recent appointment of Luigi Cappello as Chief Commercial Officer, these additions are designed to advance the three priorities guiding the company's 2026 strategy: driving customer-centricity in all aspects of the business, accelerating innovation that enables meaningful growth for its partners, and strengthening its position as an employer of choice. "Building the right leadership team has been one of my top priorities since joining Vitaquest, and Martin is an outstanding addition to that team," said Condron. "He has spent his career building the financial discipline, systems, and insight that allow manufacturing businesses to grow with confidence. As we continue investing in our capabilities and our people, his leadership will help ensure every investment we make translates into greater value for our customers." Gargiule joins Vitaquest from Spectrum Vascular, a medical device manufacturer, where he served as Vice President of Finance and Corporate Controller. There, he built the company's accounting, finance, IT, and human resources functions, led a QAD ERP implementation, and directed the financial integration of two acquisitions. He previously served as Chief Financial Officer of Douglas Electrical Components, a multi-site manufacturer of engineered components, and as Vice President of Finance at Advantice Health, a consumer health company focused on science-backed skincare brands, where he led the finance, IT, and HR functions through a period of significant growth. "Vitaquest pairs a long-standing reputation for quality with a clear vision for where the company is headed," said Gargiule. "I'm excited to join Tim and the leadership team at a time of real momentum. My focus will be on giving our teams the financial insight and infrastructure they need to move quickly, invest wisely, and deliver for our customers." Vitaquest offers a comprehensive range of services, from formulation design and product development to packaging and fulfillment, serving brands across multiple dosage forms including capsules, tablets, powders, and specialty formats. About Vitaquest International LLC Headquartered in West Caldwell, New Jersey, USA, Vitaquest International LLC is an industry-leading contract manufacturer and development partner for dietary supplements and functional foods. A leader in the design and development of new, standards-based quality initiatives, a comprehensive commitment to quality - called TotalQ(TM)- is at the core of Vitaquest as a company. With over 45 years of history, Vitaquest has the market insight, global reach, and scale of operations to support emerging and existing consumer brands from the idea to the store shelf - with flawless execution in every phase.

PR Newswire

Jun 11th, 2026

Spectrum Vascular acquires Piccolo Medical to advance real-time catheter navigation technology

Spectrum Vascular has acquired Piccolo Medical, a developer of catheter guidance technology, to accelerate commercialisation of next-generation vascular access solutions. Piccolo CEO Augustus Shanahan will join Spectrum alongside his team to advance the company's 510(k)-cleared catheter guidance products. Piccolo's technology uses proprietary blood flow sensing to guide catheter tip placement in real time, eliminating the need for confirmatory chest X-rays. The company completed its first successful patient placements of the Nav+ Stylet in May 2026. Founded in 2016 and based in San Francisco, Piccolo was spun out of the Theranova medical device incubator. Spectrum Vascular, backed by SK Capital Partners, was formed through acquisitions of vascular access businesses from Cook Medical and AngioDynamics.

Cardiac Vascular News

Jun 11th, 2026

Spectrum Vascular acquires Piccolo Medical, accelerating launch of next-generation catheter navigation technology.

Spectrum Vascular acquires Piccolo Medical, accelerating launch of next-generation catheter navigation technology. More in financial: PR News WireThis post was originally published on this site WHITE PLAINS, N.Y., June 11, 2026 /PRNewswire/ - Spectrum Vascular ("Spectrum"), a leading provider of vascular access and medication management products, today announced the acquisition of Piccolo Medical ("Piccolo"), a developer of state-of-the-art catheter guidance products. The transaction deepens a partnership focused on bringing next-generation catheter guidance technology to market and marks a significant step forward in Spectrum's mission to deliver a complete, differentiated vascular access solution to the clinical community. Augustus Shanahan, CEO of Piccolo, will join Spectrum alongside the legacy Piccolo team. The group will advance development and commercialization of its 510(k)-cleared catheter guidance and location products, building upon an innovation roadmap more than a decade in the making. Piccolo's real-time catheter guidance utilizes proprietary blood flow sensing technology to precisely guide catheter tip placement, eliminating the need for confirmatory chest X-rays. Piccolo completed the first successful patient placements of its next-generation Nav+ Stylet in May 2026, marking the beginning of a new era in guided vascular access. "Joining the Spectrum team marks an exciting new chapter for Piccolo and for vascular access as a whole," said Augustus Shanahan. "I am incredibly proud of what the Piccolo team has built over the past decade, and together with Spectrum, we now have the platform, the portfolio, and the reach to set a new standard, delivering better outcomes for patients and real economic value for the hospitals that serve them." Kenneth Miller, CEO of Spectrum, commented, "The acquisition of Piccolo Medical represents an important milestone in our mission to transform vascular access. By combining Piccolo's breakthrough navigation technology with Spectrum's vascular access portfolio and commercial reach, we are uniquely positioned to accelerate innovation, improve patient care, and redefine the standard of care for clinicians worldwide." Together, Piccolo and Spectrum will accelerate commercialization, deepen integration with Spectrum's existing catheter portfolio, and scale the next-generation navigation platform. The combined organization is poised to set a new standard of care in vascular access with greater speed and reach. About Spectrum Vascular Spectrum Vascular, backed by SK Capital Partners, is a leading provider of vascular access and medication management products engineered to reduce healthcare-acquired infections. The Company's mission is to improve the lives of patients worldwide by providing caregivers with high quality, innovative products with exceptional customer service. Innovation has been a core strategic pillar throughout Spectrum's history and many of its products have been designed to deliver antimicrobial protection and thrombus reduction. Spectrum was formed through the acquisition of the vascular access businesses of Cook Medical and AngioDynamics. For more information, please visit www.spectrumvascular.com. About Piccolo Medical Piccolo Medical is a San Francisco-based medical device company and pioneer in catheter navigation and tip confirmation technology. Founded in 2016, Piccolo was spun out of the Theranova medical device incubator and has been funded through private investors as well as prestigious grant awards from The Eunice Kennedy Shriver National Institute of Child Health and Human Development. Piccolo is committed to developing and commercializing innovative vascular access technologies designed to improve clinical outcomes, streamline procedures, and reduce complications for patients. For more information, please visit www.piccolomedical.com. SOURCE Spectrum Vascular

FinSMEs

Mar 31st, 2025

Spectrum Vascular Gains SK Capital Investment

Spectrum Vascular, a NYC-based medical device company, received an undisclosed investment from SK Capital Partners. The funds will be used to expand operations and development efforts. Spectrum Vascular, founded in 2023, specializes in vascular access and medication management products and was formed through the acquisition of the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024.

BioSpace

Jan 13th, 2025

Piccolo Medical, Inc. Announces Distribution Agreement with Spectrum Vascular

SAN FRANCISCO, Jan. 13, 2025 /PRNewswire/ - Piccolo Medical(R), an emerging leader in catheter navigation devices for vascular access procedures, is proud to announce an exclusive distribution agreement with Spectrum Vascular(TM), a leading provider of vascular access and medication management products designed to reduce healthcare acquired infections ("HAI").

Spectrum Vascular

Customer Service Representative

About the job